King's College London

Research portal

Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease

Research output: Contribution to journalArticle

Standard

Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease. / Coletto, Erika; Dolan, John S.; Pritchard, Sarah; Gant, Alex; Hikima, Atsuko; Jackson, Michael J.; Benham, Christopher D.; Ray Chaudhuri, K.; Rose, Sarah; Jenner, Peter; Iravani, Mahmoud M.

In: Nature Parkinson's Journal, Vol. 5, 31231674, 25.06.2019.

Research output: Contribution to journalArticle

Harvard

Coletto, E, Dolan, JS, Pritchard, S, Gant, A, Hikima, A, Jackson, MJ, Benham, CD, Ray Chaudhuri, K, Rose, S, Jenner, P & Iravani, MM 2019, 'Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease', Nature Parkinson's Journal, vol. 5, 31231674. https://doi.org/10.1038/s41531-019-0081-9

APA

Coletto, E., Dolan, J. S., Pritchard, S., Gant, A., Hikima, A., Jackson, M. J., ... Iravani, M. M. (2019). Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease. Nature Parkinson's Journal, 5, [31231674]. https://doi.org/10.1038/s41531-019-0081-9

Vancouver

Coletto E, Dolan JS, Pritchard S, Gant A, Hikima A, Jackson MJ et al. Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease. Nature Parkinson's Journal. 2019 Jun 25;5. 31231674. https://doi.org/10.1038/s41531-019-0081-9

Author

Coletto, Erika ; Dolan, John S. ; Pritchard, Sarah ; Gant, Alex ; Hikima, Atsuko ; Jackson, Michael J. ; Benham, Christopher D. ; Ray Chaudhuri, K. ; Rose, Sarah ; Jenner, Peter ; Iravani, Mahmoud M. / Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease. In: Nature Parkinson's Journal. 2019 ; Vol. 5.

Bibtex Download

@article{3d121ea24cbd4b8b819afa69b5f61c73,
title = "Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease",
abstract = "Bowel dysfunction is a common non-motor symptom in Parkinson's disease (PD). The main contractile neurotransmitter in the GI tract is acetylcholine (ACh), while nitric oxide (NO) causes the relaxation of smooth muscle in addition to modulating ACh release. The aim of this study was to characterise functional and neurochemical changes in the isolated ileum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated marmoset, an established model of PD motor dysfunction. While NO-synthase inhibitor L-NAME concentration dependently augmented the neurogenically-evoked contractions and inhibited the relaxations in normal tissues, it had no effects on the MPTP ileum. Immunohistochemical analyses of the myenteric plexus showed that ChAT-immunoreactivity (-ir) was significantly reduced and the density of the enteric glial cells as shown by SOX-10-ir was increased. However, no change in TH-, 5-HT-, VIP- or nNOS-ir was observed in the MPTP tissues. The enhancement of the neurogenically-evoked contractions and the inhibition of the relaxation phase by L-NAME in the control tissues is in line with NO's direct relaxing effect on smooth muscle and its indirect inhibitory effect on ACh release. The absence of the relaxation and the inefficacy of L-NAME in the MPTP tissues suggests that central dopaminergic loss dopamine may eventually lead to the impairment of NO signal coupling that affects bowel function, and this may be the result of a complex dysregulation at the level of the neuroeffector junction.",
author = "Erika Coletto and Dolan, {John S.} and Sarah Pritchard and Alex Gant and Atsuko Hikima and Jackson, {Michael J.} and Benham, {Christopher D.} and {Ray Chaudhuri}, K. and Sarah Rose and Peter Jenner and Iravani, {Mahmoud M.}",
year = "2019",
month = "6",
day = "25",
doi = "10.1038/s41531-019-0081-9",
language = "English",
volume = "5",
journal = "Nature Parkinson's Journal",
issn = "2373-8057",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease

AU - Coletto, Erika

AU - Dolan, John S.

AU - Pritchard, Sarah

AU - Gant, Alex

AU - Hikima, Atsuko

AU - Jackson, Michael J.

AU - Benham, Christopher D.

AU - Ray Chaudhuri, K.

AU - Rose, Sarah

AU - Jenner, Peter

AU - Iravani, Mahmoud M.

PY - 2019/6/25

Y1 - 2019/6/25

N2 - Bowel dysfunction is a common non-motor symptom in Parkinson's disease (PD). The main contractile neurotransmitter in the GI tract is acetylcholine (ACh), while nitric oxide (NO) causes the relaxation of smooth muscle in addition to modulating ACh release. The aim of this study was to characterise functional and neurochemical changes in the isolated ileum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated marmoset, an established model of PD motor dysfunction. While NO-synthase inhibitor L-NAME concentration dependently augmented the neurogenically-evoked contractions and inhibited the relaxations in normal tissues, it had no effects on the MPTP ileum. Immunohistochemical analyses of the myenteric plexus showed that ChAT-immunoreactivity (-ir) was significantly reduced and the density of the enteric glial cells as shown by SOX-10-ir was increased. However, no change in TH-, 5-HT-, VIP- or nNOS-ir was observed in the MPTP tissues. The enhancement of the neurogenically-evoked contractions and the inhibition of the relaxation phase by L-NAME in the control tissues is in line with NO's direct relaxing effect on smooth muscle and its indirect inhibitory effect on ACh release. The absence of the relaxation and the inefficacy of L-NAME in the MPTP tissues suggests that central dopaminergic loss dopamine may eventually lead to the impairment of NO signal coupling that affects bowel function, and this may be the result of a complex dysregulation at the level of the neuroeffector junction.

AB - Bowel dysfunction is a common non-motor symptom in Parkinson's disease (PD). The main contractile neurotransmitter in the GI tract is acetylcholine (ACh), while nitric oxide (NO) causes the relaxation of smooth muscle in addition to modulating ACh release. The aim of this study was to characterise functional and neurochemical changes in the isolated ileum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated marmoset, an established model of PD motor dysfunction. While NO-synthase inhibitor L-NAME concentration dependently augmented the neurogenically-evoked contractions and inhibited the relaxations in normal tissues, it had no effects on the MPTP ileum. Immunohistochemical analyses of the myenteric plexus showed that ChAT-immunoreactivity (-ir) was significantly reduced and the density of the enteric glial cells as shown by SOX-10-ir was increased. However, no change in TH-, 5-HT-, VIP- or nNOS-ir was observed in the MPTP tissues. The enhancement of the neurogenically-evoked contractions and the inhibition of the relaxation phase by L-NAME in the control tissues is in line with NO's direct relaxing effect on smooth muscle and its indirect inhibitory effect on ACh release. The absence of the relaxation and the inefficacy of L-NAME in the MPTP tissues suggests that central dopaminergic loss dopamine may eventually lead to the impairment of NO signal coupling that affects bowel function, and this may be the result of a complex dysregulation at the level of the neuroeffector junction.

U2 - 10.1038/s41531-019-0081-9

DO - 10.1038/s41531-019-0081-9

M3 - Article

VL - 5

JO - Nature Parkinson's Journal

JF - Nature Parkinson's Journal

SN - 2373-8057

M1 - 31231674

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454